Laennec AI Raises Pre-Seed Funding to Advance AI-Driven Chronic Disease Management
Laennec AI specializes in leveraging artificial intelligence to enhance chronic disease management, providing scalable solutions to improve patient outcomes while reducing the burden on healthcare systems.
Company Name: Laennec AI
Location: Cardiff, UK
Industry: Medical Technology (MedTech)
Funding Details:
Laennec AI raised an undisclosed amount in Pre-Seed funding from SFC Capital and OVC Ventures, supplemented by grant funding from the Welsh Government, Innovate UK, and the National Institute for Health Research (NIHR).
Purpose of Investment:
The funding will be used to accelerate the development of AI-powered medical devices.
Leadership:
- CEO: Dr. Jase John
- CTO and CRO: Dr. Arathy Varghese, PhD
Product:
Laennec AI integrates advanced algorithms into a mobile app to provide AI-driven solutions for chronic disease management. The app empowers patients to monitor conditions such as:
- Asthma
- COPD
- COVID-19
- Flu
- Heart Failure
- Arrhythmias
The platform ensures continuous remote monitoring by clinicians, bridging the gap between at-home care and professional medical oversight.
About the Company:
Laennec AI specializes in leveraging artificial intelligence to enhance chronic disease management, providing scalable solutions to improve patient outcomes while reducing the burden on healthcare systems.
